ReNeuron Group (LSE:RENE)

UK company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - RENE

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - RENE

  • Market Cap£68.220m
  • SymbolLSE:RENE
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINGB00BF5G6K95

Company Profile

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and US. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.ReNeuron Group PLC is a biotechnology firm. Its principal business involves the research and development of stem cell technology for the treatment of motor disabilities and blindness-causing diseases.

Latest RENE news

Currently there for this company. Visit our news hub for other news .

RENE Regulatory news

Currently there for this company. Visit our news hub for other news .